Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Research & Development: 2023-2024

Historic Research & Development for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $50.3 million.

  • Artiva Biotherapeutics' Research & Development rose 19.40% to $13.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $50.3 million, marking a year-over-year change of. This contributed to the annual value of $50.3 million for FY2024, which is 0.15% up from last year.
  • Per Artiva Biotherapeutics' latest filing, its Research & Development stood at $50.3 million for FY2024, which was up 0.15% from $50.3 million recorded in FY2023.
  • Artiva Biotherapeutics' 5-year Research & Development high stood at $50.3 million for FY2024, and its period low was $50.3 million during FY2023.
  • For the 2-year period, Artiva Biotherapeutics' Research & Development averaged around $50.3 million, with its median value being $50.3 million (2023).
  • Data for Artiva Biotherapeutics' Research & Development shows a peak YoY rose of 0.15% (in 2024) over the last 5 years.
  • Artiva Biotherapeutics' Research & Development (Yearly) stood at $50.3 million in 2023, then grew by 0.15% to $50.3 million in 2024.